ArticleJournal of gastroenterology2025

Potential role of Geriatric Nutritional Risk Index as a risk factor for immune-mediated adverse events during durvalumab plus tremelimumab therapy in unresectable hepatocellular carcinoma.

Hideko Ohama et al.PubMed ↗Publisher ↗

No numbers read from the abstract.